Showing 1 - 20 of 66 Items
Showing 1 - 20 of 66 Items
Sort By: Relevance
Journal Article
|Pre-Print
2024-03-08 • Scientific Reports
2024-03-08 • Scientific Reports
BACKGROUND
Tuberculosis (TB) among hospitalized patients is underdiagnosed. This study assessed systematic TB-screening, followed by an enhanced TB-diagnostic package for hospitaliz...
Tuberculosis (TB) among hospitalized patients is underdiagnosed. This study assessed systematic TB-screening, followed by an enhanced TB-diagnostic package for hospitaliz...
Journal Article
|Research
2008-08-06 • JAMA
2008-08-06 • JAMA
CONTEXT
Rifampicin-based antitubercular therapy reduces the plasma concentrations of nevirapine and efavirenz. The virological consequences of these interactions are not well describ...
Rifampicin-based antitubercular therapy reduces the plasma concentrations of nevirapine and efavirenz. The virological consequences of these interactions are not well describ...
Journal Article
|Review
2016-05-20 • International Journal of Epidemiology
2016-05-20 • International Journal of Epidemiology
Journal Article
|Research
2019-11-08 • Southern African Journal of HIV medicine
2019-11-08 • Southern African Journal of HIV medicine
Journal Article
|Research
2010-09-10 • AIDS
2010-09-10 • AIDS
OBJECTIVE: Little is known about the temporal impact of the rapid scale-up of large antiretroviral therapy (ART) services on programme outcomes. We describe patient outcomes [mortality, ...
Journal Article
|Research
2009-09-01 • South African Medical Journal
2009-09-01 • South African Medical Journal
OBJECTIVES: To introduce the combined South African cohorts of the International epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) collaboration as reflecting the South...
Journal Article
|Short Report
2015-04-28 • Southern African Journal of HIV medicine
2015-04-28 • Southern African Journal of HIV medicine
Journal Article
|Research
2010-02-17 • PLOS One
2010-02-17 • PLOS One
BACKGROUND: The majority of antiretroviral treatment programmes in sub-Saharan Africa are scaling up antiretroviral treatment using a fixed dose first-line antiretroviral regimen contain...
Journal Article
|Research
2009-06-01 • International Journal of Tuberculosis and Lung Disease
2009-06-01 • International Journal of Tuberculosis and Lung Disease
Modifications in the FASTPlaqueTB test protocol have resulted in an increase in the analytical limits of detection. This study investigated whether the performance of a modified prototyp...
Journal Article
|Research
2007-12-07 • American Journal of Respiratory and Critical Care Medicine
2007-12-07 • American Journal of Respiratory and Critical Care Medicine
RATIONALE: Two forms of the IFN-gamma release assay (IFNGRA) to detect tuberculosis infection are available, but neither has been evaluated in comparable HIV-infected and uninfected pers...
Journal Article
|Research
2014-05-14 • Lancet
2014-05-14 • Lancet
Antiretroviral therapy reduces the risk of tuberculosis, but tuberculosis is more common in people with HIV than in people without HIV. We aimed to assess the effect of isoniazid prevent...
Journal Article
|Research
2017-09-06 • PLOS One
2017-09-06 • PLOS One
Cryptococcal meningitis is one of the leading causes of death among people with HIV in Africa, primarily due to delayed presentation, poor availability and high cost of treatment. Routin...
Journal Article
|Research
2014-04-01 • International Journal of Tuberculosis and Lung Disease
2014-04-01 • International Journal of Tuberculosis and Lung Disease
SETTING: Khayelitsha, South Africa, a peri-urban township with high burdens of tuberculosis (TB), drug-resistant tuberculosis (DR-TB), and human immunodeficiency virus (HIV) infection.
Journal Article
|Research
2015-11-10 • PLOS One
2015-11-10 • PLOS One
SETTING
Khayelitsha, South Africa, with high burdens of rifampicin-resistant tuberculosis (RR-TB) and HIV co-infection.
OBJECTIVE
To describe time to antiretroviral trea...
Khayelitsha, South Africa, with high burdens of rifampicin-resistant tuberculosis (RR-TB) and HIV co-infection.
OBJECTIVE
To describe time to antiretroviral trea...
Journal Article
|Research
2019-08-01 • AIDS
2019-08-01 • AIDS
BACKGROUND
Many individuals failing first-line antiretroviral therapy (ART) in sub-Saharan Africa never initiate second-line ART or do so after significant delay. For people on ART w...
Many individuals failing first-line antiretroviral therapy (ART) in sub-Saharan Africa never initiate second-line ART or do so after significant delay. For people on ART w...
Journal Article
|Research
2021-02-03 • BMC Public Health
2021-02-03 • BMC Public Health
Background: It is estimated that 64,000 children under 15 years of age are living with HIV in the Democratic Republic of Congo (DRC). Non-disclosure - in which the child is not informed ...
Journal Article
|Research
2010-08-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2010-08-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
BACKGROUND: Many HIV-infected children in Southern Africa have been started on antiretroviral therapy (ART), but loss to follow up (LTFU) can be substantial. We analyzed mortality in chi...
Journal Article
|Research
2020-03-21 • Public Health Action
2020-03-21 • Public Health Action
Setting: In 2010, Médecins Sans Frontières set up decentralised community antiretroviral therapy (ART) refill centres ("poste de distribution communautaire", PODI) for the follow-up of s...
Journal Article
|Letter
2014-08-01 • Lancet
2014-08-01 • Lancet
Journal Article
|Research
2010-02-20 • AIDS
2010-02-20 • AIDS
OBJECTIVES: We report on outcomes after 7 years of a community-based antiretroviral therapy (ART) programme in Khayelitsha, South Africa, with death registry linkages to correct for mort...